Evidence map›Paper›PMID 32108525›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2020

Heart failure in single right ventricle congenital heart disease: physiological and molecular considerations.

Anastacia M Garcia, Jonathan-Thomas Beatty, Stephanie J Nakano

Open access · bronzeAbstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Long-term survival and complications of Fontan patients: where do we stand?American journal of cardiovascular disease · 2026
    Review
  5. Heart Failure in Adult Congenital Heart Disease.Methodist DeBakey cardiovascular journal · 2026
    Review
  6. Article
  7. Article
  8. Mitochondrial Dysfunction in Congenital Heart Disease.Journal of cardiovascular development and disease · 2025
    Review
  9. Article
  10. Management of Pediatric Heart Failure.Korean circulation journal · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Molecular Pathways and Animal Models of Hypoplastic Left Heart Syndrome.Advances in experimental medicine and biology · 2024
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anastacia M GarciaDivision of Cardiology, Department of Pediatrics, University of Colorado Denver, Aurora, Colorado.
Jonathan-Thomas BeattyDivision of Cardiology, Department of Medicine, University of Colorado Denver, Aurora, Colorado.
Stephanie J NakanoDivision of Cardiology, Department of Pediatrics, University of Colorado Denver, Aurora, Colorado.ORCID 0000-0002-2493-5842
University of Colorado Denver · US

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Institutional Career Development CoreKL2TR002534 · NCATS · UNIVERSITY OF COLORADO DENVER · PI BURNHAM, ELLEN L · 2018 to 2022
$4.6M
Training in Basic and Translational Child Health ResearchK12HD068372 · NICHD · UNIVERSITY OF COLORADO DENVER · PI DANIELS, STEPHEN R · 2011 to 2020
$3.7M
NRSA Training CoreTL1TR002533 · NCATS · UNIVERSITY OF COLORADO DENVER · PI CICUTTO, LISA · 2018 to 2022
$3.0M
Myocardial Effects of PDE5 Inhibition in Single Ventricle Heart DiseaseR01HL126928 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MIYAMOTO, SHELLEY DEANNE · 2015 to 2019
$2.7M
Functional Characterization of Phosphodiesterase 1 in Single Ventricle Heart DiseaseK08HL130592 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI NAKANO, STEPHANIE JIALING · 2017 to 2021
$826k
NCATS NIH HHS KL2 TR002534NCATS NIH HHS TL1 TR002533NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR002535NHLBI NIH HHS K08 HL130592NHLBI NIH HHS L40 HL133974NHLBI NIH HHS R01 HL126928NICHD NIH HHS K12 HD068372
6 · The paper itself

Abstract

Because of remarkable surgical and medical advances over the past several decades, there are growing numbers of infants and children living with single ventricle congenital heart disease (SV), where there is only one functional cardiac pumping chamber. Nevertheless, cardiac dysfunction (and ultimately heart failure) is a common complication in the SV population, and pharmacological heart failure therapies have largely been ineffective in mitigating the need for heart transplantation. Given that there are several inherent risk factors for ventricular dysfunction in the setting of SV in addition to probable differences in molecular adaptations to heart failure between children and adults, it is perhaps not surprising that extrapolated adult heart failure medications have had limited benefit in children with SV heart failure. Further investigations into the molecular mechanisms involved in pediatric SV heart failure may assist with risk stratification as well as development of targeted, efficacious therapies specific to this patient population. In this review, we present a brief overview of SV anatomy and physiology, with a focus on patients with a single morphological right ventricle requiring staged surgical palliation. Additionally, we discuss outcomes in the current era, risk factors associated with the progression to heart failure, present state of knowledge regarding molecular alterations in end-stage SV heart failure, and current therapeutic interventions. Potential avenues for improving SV outcomes, including identification of biomarkers of heart failure progression, implications of personalized medicine and stem cell-derived therapies, and applications of novel models of SV disease, are proposed as future directions.

Indexed as

Blalock-Taussig ProcedureHeart Bypass, RightHeart FailureHeart VentriclesHumansPatient-Specific ModelingUniventricular Heartcongenital heart diseasehypoplastic left heart syndromepediatric heart failuresingle ventricle

Identifiers

PMID32108525
PMCPMC7191494
OpenAlexW3007090723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.